Dexcel Pharma competitive analysis

Explore patent oppositions filed by Dexcel Pharma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Feb 5, 2026
Patent NumberTitleApplicantOpposition Date
Efficacious Treatment Of Nsclc And Predictive Clinical Marker Of The Responsiveness Of A Tumour To A TreatmentBOEHRINGER INGELHEIMApr 30, 2019

Latest PTAB cases involving Dexcel Pharma

Discover the latest PTAB cases involving Dexcel Pharma, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Dexcel Pharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Feb 5, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
DEXCEL PHARMA1 - - -
BOEHRINGER INGELHEIM49179109